Two Sigma Securities’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-23,121
Closed -$15.4K 1823
2026
Q1
$15.4K Sell
23,121
-4,535
-16% -$3.09K ﹤0.01% 1412
2025
Q4
$18.3K Buy
+27,656
New +$21.9K ﹤0.01% 1193
2023
Q4
Sell
-12,224
Closed -$85.8K 3100
2023
Q3
$85.8K Buy
+12,224
New +$122K ﹤0.01% 2414

Other funds holding COCH

Two Sigma Securities's COCH Position: Q2 2026 in Review

Two Sigma Securities sold out of Envoy Medical (COCH) in Q2 2026, closing a stake of 23,121 shares — an estimated $15.4K sold.

Two Sigma Securities first reported a position in COCH in Q3 2023 and held it in 3 quarters. The position peaked at $85.8K in Q3 2023. 32 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Two Sigma Securities reported no remaining Envoy Medical position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 23,121 Envoy Medical shares in Q2 2026, an estimated $15.4K.
  • Two Sigma Securities first reported a position in Envoy Medical in Q3 2023 and held it in 3 quarters.
  • Two Sigma Securities's Envoy Medical position peaked at $85.8K in Q3 2023.
  • 32 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.